0001777474-23-000001.txt : 20230621 0001777474-23-000001.hdr.sgml : 20230621 20230621150545 ACCESSION NUMBER: 0001777474-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 EFFECTIVENESS DATE: 20230621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Veralox Therapeutics Inc. CENTRAL INDEX KEY: 0001777474 IRS NUMBER: 823072071 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-484758 FILM NUMBER: 231029528 BUSINESS ADDRESS: STREET 1: 4539 METROPOLITAN COURT CITY: FREDERICK STATE: MD ZIP: 21704 BUSINESS PHONE: (301) 360-3502 MAIL ADDRESS: STREET 1: 4539 METROPOLITAN COURT CITY: FREDERICK STATE: MD ZIP: 21704 D 1 primary_doc.xml X0708 D LIVE 0001777474 Veralox Therapeutics Inc. 4539 METROPOLITAN COURT FREDERICK MD MARYLAND 21704 (301) 360-3502 DELAWARE None None Corporation true 2018 Jonathan Mow C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Executive Officer Director Alex Martin C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Director Jamie Stiff C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Director Katie Ellias C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Director Benjamin Scruggs C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Director Megan Krench C/o Veralox Therapeutics Inc. 4539 Metropolitan Court Frederick MD MARYLAND 21704 Director Biotechnology Decline to Disclose 06b false 2023-06-01 false true true Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof. false 0 24999971 24013521 986450 false 14 0 0 0 false Veralox Therapeutics Inc. /s/Jonathan Mow Jonathan Mow Chief Executive Officer 2023-06-21